{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:01:16Z","timestamp":1776765676759,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.yexcr.2023.113666","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:08:45Z","timestamp":1685671725000},"page":"113666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression"],"prefix":"10.1016","volume":"429","author":[{"given":"Ting-Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-7950","authenticated-orcid":false,"given":"Yu-Ting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-1827","authenticated-orcid":false,"given":"Xi-Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Han","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yexcr.2023.113666_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113666_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/cvr\/cvy022","article-title":"Smooth muscle cell fate and plasticity in atherosclerosis","volume":"114","author":"Allahverdian","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.yexcr.2023.113666_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/ATVBAHA.116.307306","article-title":"Enzymatically modified low-density lipoprotein promotes foam cell formation in smooth muscle cells via macropinocytosis and enhances receptor-mediated uptake of oxidized low-density lipoprotein","volume":"36","author":"Chellan","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2023.113666_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/bmb\/ldy006","article-title":"CD36 and lipid metabolism in the evolution of atherosclerosis","volume":"126","author":"Zhao","year":"2018","journal-title":"Br. Med. Bull."},{"issue":"9","key":"10.1016\/j.yexcr.2023.113666_bib5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of ox-LDL and LOX-1 in atherogenesis","volume":"26","author":"Kattoor","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.yexcr.2023.113666_bib6","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/01.CIR.99.24.3110","article-title":"Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions","volume":"99","author":"Kataoka","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yexcr.2023.113666_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-2275(20)32566-9","article-title":"Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL","volume":"39","author":"Calvo","year":"1998","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.yexcr.2023.113666_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5\u20136","key":"10.1016\/j.yexcr.2023.113666_bib9","doi-asserted-by":"crossref","first-page":"151169","DOI":"10.1016\/j.ejcb.2021.151169","article-title":"Oxidized low-density lipoprotein induced hepatoma-derived growth factor upregulation mediates foam cell formation of cultured rat aortic vascular smooth muscle cells","volume":"100","author":"Cheng","year":"2021","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.yexcr.2023.113666_bib10","volume":"10","author":"Zingg","year":"2021"},{"key":"10.1016\/j.yexcr.2023.113666_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.redox.2018.03.003","article-title":"MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1","volume":"16","author":"Dai","year":"2018","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113666_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"Holmen","year":"2014","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113666_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.yexcr.2023.113666_bib14","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.yexcr.2023.113666_bib15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hep.29021","article-title":"TM6SF2 rs58542926 impacts lipid processing in liver and small intestine","volume":"65","author":"O'Hare","year":"2017","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.yexcr.2023.113666_bib16","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yexcr.2023.113666_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcmgh.2021.12.008","article-title":"Hepatic TM6SF2 is required for lipidation of VLDL in a pre-golgi compartment in mice and rats","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.yexcr.2023.113666_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.yexcr.2023.113666_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000056784","article-title":"Cloning of the novel gene TM6SF1 reveals conservation of clusters of paralogous genes between human chromosomes 15q24-->q26 and 19p13.3-->p12","volume":"90","author":"Carim-Todd","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"issue":"24","key":"10.1016\/j.yexcr.2023.113666_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144079","article-title":"Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans","volume":"5","author":"Boren","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.yexcr.2023.113666_bib21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2016.01.005","article-title":"Hepatic transmembrane 6 superfamily member 2 regulates cholesterol metabolism in mice","volume":"150","author":"Fan","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.yexcr.2023.113666_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"Sookoian","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.yexcr.2023.113666_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ijpo.12032","article-title":"TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children","volume":"11","author":"Grandone","year":"2016","journal-title":"Pediatr Obes"},{"issue":"6","key":"10.1016\/j.yexcr.2023.113666_bib24","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jhep.2015.01.040","article-title":"The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese","volume":"62","author":"Wang","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.yexcr.2023.113666_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2014.04.047","article-title":"Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese","volume":"61","author":"Wong","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.yexcr.2023.113666_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.28283","article-title":"Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: a multiethnic study","volume":"63","author":"Goffredo","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.yexcr.2023.113666_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hep.28475","article-title":"Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes","volume":"64","author":"Eslam","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.yexcr.2023.113666_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.dld.2015.10.003","article-title":"Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children","volume":"48","author":"Mancina","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.yexcr.2023.113666_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/pr.2016.3","article-title":"Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study","volume":"79","author":"Viitasalo","year":"2016","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.yexcr.2023.113666_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.yexcr.2023.113666_bib31","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.yexcr.2023.113666_bib32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.yexcr.2023.113666_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2023.113666_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fgene.2014.00439","article-title":"TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease","volume":"5","author":"Sanchez-Pulido","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2023.113666_bib35","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.yexcr.2023.113666_bib36","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.120.046672","article-title":"Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis","volume":"142","author":"Alencar","year":"2020","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.yexcr.2023.113666_bib37","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.3390\/cells11182877","article-title":"Myeloid TM6SF2 deficiency inhibits atherosclerosis","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.yexcr.2023.113666_bib38","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.10.5.680","article-title":"Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"14","key":"10.1016\/j.yexcr.2023.113666_bib39","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/hmg\/ddx159","article-title":"Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis","volume":"26","author":"Ehrhardt","year":"2017","journal-title":"Hum. Mol. Genet."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482723002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:45:28Z","timestamp":1757997928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482723002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0014482723002136"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113666","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113666"}}